CSBR
Champions Oncology·NASDAQ
--
--(--)
--
--(--)
CSBR fundamentals
Champions Oncology (CSBR) expects to report earnings on Dec 15, 2025, with estimated revenue of 14.04M (YoY +4.00%), and EPS at 0 (YoY -100.00%).
Revenue estimate / YoY
14.04M
+4.00%
EPS estimate / YoY
0
-100.00%
Report date
Dec 15, 2025
EPS
Revenue
Revenue & Expenses
CSBR has released its 2026 Q1 earnings report, with revenue of 13.99M, reflecting a YoY change of -0.47%, and net profit of -466.00K, showing a YoY change of -135.49%. The Sankey diagram below clearly presents CSBR's revenue sources and cost distribution.
Key Indicators
Champions Oncology (CSBR) key financial stats and ratios, covering profitability, financial health, and leverage.
Champions Oncology (CSBR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Champions Oncology (CSBR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Champions Oncology (CSBR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Champions Oncology (CSBR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Champions Oncology (CSBR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Champions Oncology's latest dividend and current dividend yield?What were the key takeaways from Champions Oncology's earnings call?What is Champions Oncology's gross profit margin?Did Champions Oncology beat or miss consensus estimates last quarter?What guidance did Champions Oncology's management provide for the next earnings period?What does Champions Oncology do and what are its main business segments?What factors drove the changes in Champions Oncology's revenue and profit?What were the key takeaways from Champions Oncology’s earnings call?
